| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.58e-06 | 320 | 41 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.05e-06 | 326 | 41 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX6 SOX5 FOXP1 FOXP4 KMT2D SALL3 SATB1 ZNF853 FOXP2 SOX13 YLPM1 | 9.29e-05 | 1412 | 41 | 11 | GO:0000981 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.73e-04 | 303 | 41 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.73e-04 | 1160 | 41 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 5.80e-04 | 1459 | 41 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 7.84e-04 | 1244 | 41 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 9.14e-04 | 1271 | 41 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 9.41e-04 | 562 | 41 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.44e-03 | 1356 | 41 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.09e-03 | 33 | 41 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | protein sequestering activity | 2.21e-03 | 34 | 41 | 2 | GO:0140311 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.96e-03 | 140 | 41 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.75e-03 | 739 | 41 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.11e-03 | 753 | 41 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.52e-03 | 582 | 41 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | molecular sequestering activity | 6.54e-03 | 59 | 41 | 2 | GO:0140313 | |
| GeneOntologyBiologicalProcess | negative regulation of lung goblet cell differentiation | 4.05e-06 | 2 | 42 | 2 | GO:1901250 | |
| GeneOntologyBiologicalProcess | striatum development | 1.18e-05 | 22 | 42 | 3 | GO:0021756 | |
| GeneOntologyBiologicalProcess | regulation of lung goblet cell differentiation | 1.21e-05 | 3 | 42 | 2 | GO:1901249 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 1.21e-05 | 3 | 42 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 1.30e-05 | 150 | 42 | 5 | GO:0000018 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX6 SOX5 GON4L FOXP1 FOXP4 SATB1 FOXP2 CREBBP SOX13 PHC2 EPC1 YLPM1 | 1.48e-05 | 1399 | 42 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX6 SOX5 GON4L FOXP1 FOXP4 SATB1 FOXP2 CREBBP SOX13 PHC2 EPC1 YLPM1 | 1.64e-05 | 1413 | 42 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 2.10e-05 | 80 | 42 | 4 | GO:0045911 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell differentiation | 2.42e-05 | 4 | 42 | 2 | GO:2000741 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 2.43e-05 | 83 | 42 | 4 | GO:0010569 | |
| GeneOntologyBiologicalProcess | subpallium development | 2.48e-05 | 28 | 42 | 3 | GO:0021544 | |
| GeneOntologyBiologicalProcess | spinal cord oligodendrocyte cell differentiation | 4.03e-05 | 5 | 42 | 2 | GO:0021529 | |
| GeneOntologyBiologicalProcess | lung goblet cell differentiation | 6.04e-05 | 6 | 42 | 2 | GO:0060480 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PAXIP1 SOX6 MED12L LIF FOXP1 KMT2D MAML2 CREBBP NFKBIA EPC1 TOX3 | 7.66e-05 | 1390 | 42 | 11 | GO:0045944 |
| GeneOntologyBiologicalProcess | lobar bronchus epithelium development | 8.45e-05 | 7 | 42 | 2 | GO:0060481 | |
| GeneOntologyBiologicalProcess | DNA recombination | 9.44e-05 | 368 | 42 | 6 | GO:0006310 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 9.81e-05 | 44 | 42 | 3 | GO:1905168 | |
| GeneOntologyBiologicalProcess | lobar bronchus development | 1.12e-04 | 8 | 42 | 2 | GO:0060482 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 1.13e-04 | 123 | 42 | 4 | GO:0051153 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 2.19e-04 | 146 | 42 | 4 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal stem cell differentiation | 2.20e-04 | 11 | 42 | 2 | GO:2000739 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.21e-04 | 1053 | 42 | 9 | GO:0000122 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 2.60e-04 | 61 | 42 | 3 | GO:0060428 | |
| GeneOntologyBiologicalProcess | bronchus development | 3.11e-04 | 13 | 42 | 2 | GO:0060433 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell differentiation | 3.63e-04 | 14 | 42 | 2 | GO:0072497 | |
| GeneOntologyBiologicalProcess | lung secretory cell differentiation | 4.18e-04 | 15 | 42 | 2 | GO:0061140 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 5.71e-04 | 188 | 42 | 4 | GO:0000724 | |
| GeneOntologyBiologicalProcess | recombinational repair | 6.42e-04 | 194 | 42 | 4 | GO:0000725 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 7.06e-04 | 199 | 42 | 4 | GO:0051147 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 9.25e-04 | 564 | 42 | 6 | GO:0051052 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 9.54e-04 | 95 | 42 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | cartilage condensation | 9.97e-04 | 23 | 42 | 2 | GO:0001502 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.09e-03 | 24 | 42 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte differentiation | 1.09e-03 | 24 | 42 | 2 | GO:0032332 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.29e-03 | 234 | 42 | 4 | GO:0006282 | |
| GeneOntologyCellularComponent | chromatin | SOX6 SOX5 GON4L EPC2 FOXP1 FOXP4 SATB1 FOXP2 CREBBP SOX13 PHC2 EPC1 | 1.74e-05 | 1480 | 41 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | piccolo histone acetyltransferase complex | 2.25e-05 | 4 | 41 | 2 | GO:0032777 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.45e-04 | 12 | 41 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.29e-04 | 75 | 41 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 8.29e-04 | 94 | 41 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.11e-03 | 104 | 41 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.24e-03 | 108 | 41 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.27e-03 | 109 | 41 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.79e-03 | 32 | 41 | 2 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.79e-03 | 32 | 41 | 2 | GO:0035267 | |
| GeneOntologyCellularComponent | transferase complex | 2.46e-03 | 963 | 41 | 7 | GO:1990234 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.52e-03 | 45 | 41 | 2 | GO:1902562 | |
| HumanPheno | Prominent fingertip pads | 1.35e-07 | 46 | 15 | 5 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 1.68e-07 | 48 | 15 | 5 | HP:0011298 | |
| HumanPheno | Autistic behavior | 2.62e-06 | 678 | 15 | 10 | HP:0000729 | |
| HumanPheno | Gastroesophageal reflux | 3.05e-06 | 517 | 15 | 9 | HP:0002020 | |
| HumanPheno | Short attention span | 3.05e-06 | 517 | 15 | 9 | HP:0000736 | |
| HumanPheno | Reduced attention regulation | 3.54e-06 | 526 | 15 | 9 | HP:5200044 | |
| HumanPheno | Hyperactivity | 5.82e-06 | 558 | 15 | 9 | HP:0000752 | |
| HumanPheno | Motor stereotypy | 6.19e-06 | 280 | 15 | 7 | HP:0000733 | |
| HumanPheno | Diagnostic behavioral phenotype | 6.48e-06 | 747 | 15 | 10 | HP:0025783 | |
| HumanPheno | Premature thelarche | 1.37e-05 | 17 | 15 | 3 | HP:0010314 | |
| HumanPheno | Expressive language delay | 1.63e-05 | 56 | 15 | 4 | HP:0002474 | |
| HumanPheno | Language delay | 1.63e-05 | 56 | 15 | 4 | HP:0002336 | |
| HumanPheno | Abnormally increased volition | 2.61e-05 | 869 | 15 | 10 | HP:5200263 | |
| HumanPheno | Abnormality of the palpebral fissures | 2.93e-05 | 880 | 15 | 10 | HP:0008050 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 3.76e-05 | 368 | 15 | 7 | HP:0031432 | |
| HumanPheno | Perseverative thought | 4.40e-05 | 377 | 15 | 7 | HP:0030223 | |
| HumanPheno | Disordered formal thought process | 5.13e-05 | 386 | 15 | 7 | HP:0025769 | |
| HumanPheno | Thick eyebrow | 5.56e-05 | 154 | 15 | 5 | HP:0000574 | |
| HumanPheno | Frontal bossing | 5.91e-05 | 738 | 15 | 9 | HP:0002007 | |
| HumanPheno | Abnormal shape of the frontal region | 6.11e-05 | 741 | 15 | 9 | HP:0011218 | |
| HumanPheno | Abnormal stomach morphology | 6.18e-05 | 742 | 15 | 9 | HP:0002577 | |
| HumanPheno | Abnormal frontal bone morphology | 6.18e-05 | 742 | 15 | 9 | HP:0430000 | |
| HumanPheno | Abnormality of the forehead | SOX6 MED12L SOX5 FOXP1 KMT2D SATB1 MBD5 CELF2 PUF60 CREBBP NFKBIA | 6.67e-05 | 1208 | 15 | 11 | HP:0000290 |
| HumanPheno | Abnormal thought pattern | 6.89e-05 | 404 | 15 | 7 | HP:5200269 | |
| HumanPheno | Short columella | 7.21e-05 | 29 | 15 | 3 | HP:0002000 | |
| HumanPheno | Clinodactyly | 7.75e-05 | 574 | 15 | 8 | HP:0030084 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 9.39e-05 | 87 | 15 | 4 | HP:0000614 | |
| HumanPheno | Branchial cyst | 1.21e-04 | 6 | 15 | 2 | HP:0009796 | |
| HumanPheno | Bilateral renal hypoplasia | 1.21e-04 | 6 | 15 | 2 | HP:0012584 | |
| HumanPheno | Abnormal size of the palpebral fissures | 1.22e-04 | 298 | 15 | 6 | HP:0200007 | |
| HumanPheno | Disinhibition | 1.22e-04 | 807 | 15 | 9 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 1.22e-04 | 807 | 15 | 9 | HP:0000719 | |
| HumanPheno | Abnormal response to social norms | 1.22e-04 | 807 | 15 | 9 | HP:5200123 | |
| HumanPheno | Social disinhibition | 1.22e-04 | 807 | 15 | 9 | HP:5200029 | |
| HumanPheno | Reduced impulse control | 1.24e-04 | 1032 | 15 | 10 | HP:5200045 | |
| HumanPheno | Nasolacrimal duct obstruction | 1.39e-04 | 36 | 15 | 3 | HP:0000579 | |
| HumanPheno | Nasogastric tube feeding in infancy | 1.51e-04 | 37 | 15 | 3 | HP:0011470 | |
| HumanPheno | Narrow palate | 2.02e-04 | 202 | 15 | 5 | HP:0000189 | |
| HumanPheno | Abnormal fingertip morphology | 2.07e-04 | 203 | 15 | 5 | HP:0001211 | |
| HumanPheno | Prominent nose | 2.34e-04 | 110 | 15 | 4 | HP:0000448 | |
| HumanPheno | Abnormal eyebrow morphology | 2.46e-04 | 674 | 15 | 8 | HP:0000534 | |
| HumanPheno | Abnormal hair pattern | 2.51e-04 | 676 | 15 | 8 | HP:0010720 | |
| HumanPheno | Downslanted palpebral fissures | 2.59e-04 | 497 | 15 | 7 | HP:0000494 | |
| HumanPheno | Delayed speech and language development | 2.61e-04 | 1123 | 15 | 10 | HP:0000750 | |
| HumanPheno | Abnormality of calvarial morphology | 2.85e-04 | 1134 | 15 | 10 | HP:0002648 | |
| HumanPheno | Pilomatrixoma | 2.88e-04 | 9 | 15 | 2 | HP:0030434 | |
| HumanPheno | Thoracic kyphosis | 2.97e-04 | 117 | 15 | 4 | HP:0002942 | |
| HumanPheno | Abnormal eyelid morphology | SOX6 MED12L SOX5 FOXP1 KMT2D SATB1 MBD5 CELF2 FOXP2 PUF60 CREBBP | 3.00e-04 | 1408 | 15 | 11 | HP:0000492 |
| HumanPheno | Abnormal social development | 3.13e-04 | 908 | 15 | 9 | HP:0025732 | |
| HumanPheno | Abnormal thoracic spine morphology | 3.17e-04 | 119 | 15 | 4 | HP:0100711 | |
| HumanPheno | Abnormal hair morphology | SOX6 MED12L SOX5 FOXP1 KMT2D SATB1 MBD5 FOXP2 PUF60 CREBBP NFKBIA | 3.35e-04 | 1424 | 15 | 11 | HP:0001595 |
| HumanPheno | Abnormal external nose morphology | 3.35e-04 | 916 | 15 | 9 | HP:0010938 | |
| HumanPheno | Abnormal midface morphology | 3.35e-04 | 704 | 15 | 8 | HP:0000309 | |
| HumanPheno | Short palpebral fissure | 3.48e-04 | 122 | 15 | 4 | HP:0012745 | |
| HumanPheno | Overweight | 3.51e-04 | 49 | 15 | 3 | HP:0025502 | |
| HumanPheno | Feeding difficulties | MED12L SOX5 FOXP1 KMT2D MBD5 CELF2 FOXP2 PUF60 CREBBP NFKBIA | 3.69e-04 | 1168 | 15 | 10 | HP:0011968 |
| HumanPheno | Open mouth | 3.71e-04 | 124 | 15 | 4 | HP:0000194 | |
| HumanPheno | Abnormal lacrimal duct morphology | 3.73e-04 | 50 | 15 | 3 | HP:0011481 | |
| HumanPheno | Abnormal esophagus physiology | 3.87e-04 | 933 | 15 | 9 | HP:0025270 | |
| HumanPheno | Language impairment | 3.97e-04 | 1178 | 15 | 10 | HP:0002463 | |
| HumanPheno | Long eyelashes | 4.31e-04 | 129 | 15 | 4 | HP:0000527 | |
| HumanPheno | Slanting of the palpebral fissure | 4.72e-04 | 739 | 15 | 8 | HP:0200006 | |
| HumanPheno | Hypoplasia of the middle phalanges of the hand | 4.94e-04 | 55 | 15 | 3 | HP:0010240 | |
| HumanPheno | Short middle phalanx of finger | 4.94e-04 | 55 | 15 | 3 | HP:0005819 | |
| HumanPheno | Abnormal nasal tip morphology | 5.05e-04 | 386 | 15 | 6 | HP:0000436 | |
| HumanPheno | Unilateral ptosis | 5.25e-04 | 12 | 15 | 2 | HP:0007687 | |
| HumanPheno | Steroetypic upper-extremity movements | 5.50e-04 | 57 | 15 | 3 | HP:5200018 | |
| HumanPheno | Thoracic scoliosis | 6.39e-04 | 60 | 15 | 3 | HP:0002943 | |
| HumanPheno | Abnormal nasal dorsum morphology | 6.79e-04 | 262 | 15 | 5 | HP:0011119 | |
| HumanPheno | Abnormal calvaria morphology | 6.83e-04 | 1254 | 15 | 10 | HP:0002683 | |
| HumanPheno | Hemivertebrae | 7.04e-04 | 62 | 15 | 3 | HP:0002937 | |
| HumanPheno | Aplasia/Hypoplasia of the middle phalanges of the hand | 7.04e-04 | 62 | 15 | 3 | HP:0009843 | |
| HumanPheno | Hypoplastic aortic arch | 7.22e-04 | 14 | 15 | 2 | HP:0012304 | |
| HumanPheno | Abnormal motivation | 7.27e-04 | 1263 | 15 | 10 | HP:5200275 | |
| HumanPheno | Abnormal volitional state | 7.27e-04 | 1263 | 15 | 10 | HP:0025780 | |
| HumanPheno | Functional abnormality of the gastrointestinal tract | MED12L SOX5 KMT2D SATB1 MBD5 CELF2 FOXP2 PUF60 CREBBP NFKBIA | 7.62e-04 | 1270 | 15 | 10 | HP:0012719 |
| HumanPheno | Feeding difficulties in infancy | 7.84e-04 | 594 | 15 | 7 | HP:0008872 | |
| HumanPheno | Reduced circulating growth hormone concentration | 8.31e-04 | 15 | 15 | 2 | HP:0034323 | |
| HumanPheno | Hypertrichosis | 8.49e-04 | 425 | 15 | 6 | HP:0000998 | |
| HumanPheno | High, narrow palate | 8.87e-04 | 156 | 15 | 4 | HP:0002705 | |
| HumanPheno | Abnormality of tear glands or tear production | 8.87e-04 | 156 | 15 | 4 | HP:0000521 | |
| HumanPheno | Recurrent maladaptive behavior | 8.89e-04 | 1293 | 15 | 10 | HP:5200241 | |
| HumanPheno | Square face | 9.48e-04 | 16 | 15 | 2 | HP:0000321 | |
| HumanPheno | Drooling | 9.99e-04 | 161 | 15 | 4 | HP:0002307 | |
| HumanPheno | Vertebral segmentation defect | 1.02e-03 | 162 | 15 | 4 | HP:0003422 | |
| HumanPheno | Hypermetropia | 1.05e-03 | 288 | 15 | 5 | HP:0000540 | |
| HumanPheno | Overlapping toe | 1.09e-03 | 72 | 15 | 3 | HP:0001845 | |
| HumanPheno | Abnormal middle phalanx morphology of the hand | 1.14e-03 | 73 | 15 | 3 | HP:0009833 | |
| HumanPheno | Abnormality of mouth shape | 1.15e-03 | 294 | 15 | 5 | HP:0011338 | |
| HumanPheno | Finger clinodactyly | 1.18e-03 | 452 | 15 | 6 | HP:0040019 | |
| HumanPheno | Abnormal esophagus morphology | 1.19e-03 | 1078 | 15 | 9 | HP:0002031 | |
| HumanPheno | Skin appendage neoplasm | 1.21e-03 | 18 | 15 | 2 | HP:0012842 | |
| HumanPheno | Excessive salivation | 1.22e-03 | 170 | 15 | 4 | HP:0003781 | |
| HumanPheno | Abnormal dental morphology | 1.24e-03 | 299 | 15 | 5 | HP:0006482 | |
| HumanPheno | Broad hallux | 1.28e-03 | 76 | 15 | 3 | HP:0010055 | |
| HumanPheno | Cleft hard palate | 1.33e-03 | 77 | 15 | 3 | HP:0410005 | |
| HumanPheno | Recurrent ear infections | 1.34e-03 | 19 | 15 | 2 | HP:0410018 | |
| HumanPheno | High forehead | 1.38e-03 | 306 | 15 | 5 | HP:0000348 | |
| HumanPheno | Downturned corners of mouth | 1.58e-03 | 182 | 15 | 4 | HP:0002714 | |
| HumanPheno | Overfolded helix | 1.59e-03 | 82 | 15 | 3 | HP:0000396 | |
| MousePheno | postnatal lethality, complete penetrance | 1.09e-05 | 445 | 35 | 8 | MP:0011085 | |
| MousePheno | increased grooming behavior | 3.35e-05 | 74 | 35 | 4 | MP:0001441 | |
| Domain | FOXP-CC | 4.22e-08 | 4 | 42 | 3 | PF16159 | |
| Domain | FOXP-CC | 4.22e-08 | 4 | 42 | 3 | IPR032354 | |
| Domain | HMG_box | 1.19e-07 | 53 | 42 | 5 | PF00505 | |
| Domain | HMG | 1.31e-07 | 54 | 42 | 5 | SM00398 | |
| Domain | - | 1.44e-07 | 55 | 42 | 5 | 1.10.30.10 | |
| Domain | HMG_box_dom | 3.36e-07 | 65 | 42 | 5 | IPR009071 | |
| Domain | Enhancer_polycomb_C | 4.94e-06 | 2 | 42 | 2 | IPR009607 | |
| Domain | Enhancer_polycomb | 4.94e-06 | 2 | 42 | 2 | IPR024943 | |
| Domain | E_Pc_C | 4.94e-06 | 2 | 42 | 2 | PF06752 | |
| Domain | HMG_BOX_2 | 6.44e-06 | 54 | 42 | 4 | PS50118 | |
| Domain | Enhancer_polycomb-like_N | 1.37e-04 | 8 | 42 | 2 | IPR019542 | |
| Domain | EPL1 | 1.37e-04 | 8 | 42 | 2 | PF10513 | |
| Domain | TF_fork_head_CS_2 | 1.50e-04 | 46 | 42 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 1.60e-04 | 47 | 42 | 3 | IPR018122 | |
| Domain | FORK_HEAD_3 | 1.81e-04 | 49 | 42 | 3 | PS50039 | |
| Domain | FH | 1.81e-04 | 49 | 42 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.81e-04 | 49 | 42 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.81e-04 | 49 | 42 | 3 | PS00658 | |
| Domain | Forkhead | 1.81e-04 | 49 | 42 | 3 | PF00250 | |
| Domain | Fork_head_dom | 1.81e-04 | 49 | 42 | 3 | IPR001766 | |
| Domain | ZF_ZZ_2 | 7.38e-04 | 18 | 42 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 7.38e-04 | 18 | 42 | 2 | PS01357 | |
| Domain | ZZ | 7.38e-04 | 18 | 42 | 2 | PF00569 | |
| Domain | Znf_ZZ | 8.24e-04 | 19 | 42 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 8.24e-04 | 19 | 42 | 2 | SM00291 | |
| Domain | tRNA-bd_arm | 1.32e-03 | 24 | 42 | 2 | IPR010978 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.56e-03 | 775 | 42 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.59e-03 | 777 | 42 | 7 | PS00028 | |
| Domain | Znf_C2H2-like | 1.82e-03 | 796 | 42 | 7 | IPR015880 | |
| Domain | Znf_C2H2 | 1.94e-03 | 805 | 42 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.98e-03 | 808 | 42 | 7 | SM00355 | |
| Domain | UBA-like | 9.11e-03 | 64 | 42 | 2 | IPR009060 | |
| Pathway | WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS | 3.40e-05 | 30 | 30 | 3 | M39775 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 5.81e-05 | 330 | 30 | 6 | M7847 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 9.44e-05 | 42 | 30 | 3 | M27272 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.20e-04 | 233 | 30 | 5 | M27099 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY | 1.95e-04 | 10 | 30 | 2 | M47599 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY | 2.85e-04 | 12 | 30 | 2 | M47600 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY | 3.92e-04 | 14 | 30 | 2 | M47567 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.92e-04 | 14 | 30 | 2 | M27808 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.95e-04 | 301 | 30 | 5 | MM15983 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 4.52e-04 | 15 | 30 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 4.52e-04 | 15 | 30 | 2 | M10183 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY | 4.52e-04 | 15 | 30 | 2 | M47566 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 5.16e-04 | 16 | 30 | 2 | M27121 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY | 5.16e-04 | 16 | 30 | 2 | M47453 | |
| Pathway | REACTOME_SUMOYLATION | 6.53e-04 | 189 | 30 | 4 | M27214 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.12e-04 | 20 | 30 | 2 | M27881 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 9.85e-04 | 22 | 30 | 2 | MM1443 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.08e-03 | 23 | 30 | 2 | M2821 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.27e-03 | 25 | 30 | 2 | M27880 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 1.38e-03 | 26 | 30 | 2 | M47923 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.51e-03 | 237 | 30 | 4 | M27786 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.60e-03 | 28 | 30 | 2 | M6177 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.72e-03 | 29 | 30 | 2 | M48076 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.02e-03 | 119 | 30 | 3 | M607 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.09e-03 | 32 | 30 | 2 | M39521 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.09e-03 | 32 | 30 | 2 | MM14975 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 2.16e-03 | 122 | 30 | 3 | M29689 | |
| Pathway | SIG_CD40PATHWAYMAP | 2.35e-03 | 34 | 30 | 2 | M12705 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.35e-03 | 34 | 30 | 2 | M46422 | |
| Pubmed | PAXIP1 SOX6 SOX5 GON4L EPC2 FOXP1 FOXP4 KMT2D SATB1 FOXP2 CREBBP SOX13 NFKBIA KCMF1 EPC1 YLPM1 TNRC6A | 2.37e-13 | 1429 | 42 | 17 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | PAXIP1 SOX5 EPC2 FOXP1 FOXP4 KMT2D SATB1 FOXP2 CREBBP SOX13 EPC1 | 3.06e-13 | 351 | 42 | 11 | 38297188 |
| Pubmed | 7.89e-13 | 28 | 42 | 6 | 29365100 | ||
| Pubmed | 6.65e-11 | 23 | 42 | 5 | 9225980 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.83e-10 | 398 | 42 | 9 | 35016035 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 14516685 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 1.64e-09 | 3 | 42 | 3 | 19907493 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 28507505 | ||
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 1.64e-09 | 3 | 42 | 3 | 25027557 | |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 14701752 | ||
| Pubmed | Identification and characterization of T reg-like cells in zebrafish. | 6.54e-09 | 4 | 42 | 3 | 29066577 | |
| Pubmed | 1.57e-08 | 65 | 42 | 5 | 22496869 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 16627753 | ||
| Pubmed | 3.20e-08 | 268 | 42 | 7 | 33640491 | ||
| Pubmed | 3.26e-08 | 808 | 42 | 10 | 20412781 | ||
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 17619227 | ||
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 28591638 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 5.64e-08 | 857 | 42 | 10 | 25609649 | |
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 20185820 | ||
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 9.13e-08 | 8 | 42 | 3 | 18703590 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 9.66e-08 | 908 | 42 | 10 | 19274049 | |
| Pubmed | 1.95e-07 | 10 | 42 | 3 | 10037800 | ||
| Pubmed | Forkhead Box Protein P1 Is Dispensable for Retina but Essential for Lens Development. | 1.95e-07 | 10 | 42 | 3 | 28384713 | |
| Pubmed | Foxp1/2/4 regulate endochondral ossification as a suppresser complex. | 2.68e-07 | 11 | 42 | 3 | 25527076 | |
| Pubmed | 3.58e-07 | 12 | 42 | 3 | 26525805 | ||
| Pubmed | 3.58e-07 | 12 | 42 | 3 | 34234180 | ||
| Pubmed | 5.91e-07 | 14 | 42 | 3 | 8921394 | ||
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 7.38e-07 | 15 | 42 | 3 | 30871468 | |
| Pubmed | 9.07e-07 | 16 | 42 | 3 | 26021489 | ||
| Pubmed | 9.07e-07 | 16 | 42 | 3 | 22542185 | ||
| Pubmed | 9.07e-07 | 645 | 42 | 8 | 25281560 | ||
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 1.10e-06 | 17 | 42 | 3 | 27241892 | |
| Pubmed | 1.32e-06 | 18 | 42 | 3 | 26864488 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 30031127 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 1.42e-06 | 2 | 42 | 2 | 30104377 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 35759955 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 9524265 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 9735366 | ||
| Pubmed | Generation of mice harboring a Sox5 conditional null allele. | 1.42e-06 | 2 | 42 | 2 | 18543318 | |
| Pubmed | Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. | 1.42e-06 | 2 | 42 | 2 | 19924292 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 24893771 | ||
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 1.42e-06 | 2 | 42 | 2 | 15056695 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 25853299 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 27224915 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 11358962 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 28741757 | ||
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 1.42e-06 | 2 | 42 | 2 | 27999180 | |
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 1.42e-06 | 2 | 42 | 2 | 38761373 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 11585348 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 26647308 | ||
| Pubmed | 1.84e-06 | 20 | 42 | 3 | 11404013 | ||
| Pubmed | 2.15e-06 | 21 | 42 | 3 | 29659575 | ||
| Pubmed | Foxp1 Regulates Neural Stem Cell Self-Renewal and Bias Toward Deep Layer Cortical Fates. | 2.48e-06 | 22 | 42 | 3 | 32049024 | |
| Pubmed | Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. | 3.70e-06 | 25 | 42 | 3 | 17428829 | |
| Pubmed | 4.18e-06 | 26 | 42 | 3 | 27341756 | ||
| Pubmed | SoxD genes are required for adult neural stem cell activation. | 4.27e-06 | 3 | 42 | 2 | 35108528 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 34463256 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 26045173 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 26150426 | ||
| Pubmed | Generation of mice harboring a Sox6 conditional null allele. | 4.27e-06 | 3 | 42 | 2 | 16652367 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 15529345 | ||
| Pubmed | Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. | 4.27e-06 | 3 | 42 | 2 | 12687690 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 36893259 | ||
| Pubmed | SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. | 4.27e-06 | 3 | 42 | 2 | 21728837 | |
| Pubmed | SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells. | 4.27e-06 | 3 | 42 | 2 | 28687615 | |
| Pubmed | Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells. | 4.27e-06 | 3 | 42 | 2 | 24166297 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 21094641 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 21401405 | ||
| Pubmed | Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization. | 4.27e-06 | 3 | 42 | 2 | 28204507 | |
| Pubmed | 6.36e-06 | 591 | 42 | 7 | 15231748 | ||
| Pubmed | Tangential Intrahypothalamic Migration of the Mouse Ventral Premamillary Nucleus and Fgf8 Signaling. | 7.19e-06 | 31 | 42 | 3 | 34095148 | |
| Pubmed | 7.19e-06 | 31 | 42 | 3 | 36476860 | ||
| Pubmed | 7.93e-06 | 32 | 42 | 3 | 16516881 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 28398509 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 18559420 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 32960357 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 21262861 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 27088802 | ||
| Pubmed | HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis. | 8.53e-06 | 4 | 42 | 2 | 30270123 | |
| Pubmed | Extrinsic Regulators of mRNA Translation in Developing Brain: Story of WNTs. | 8.53e-06 | 4 | 42 | 2 | 33525513 | |
| Pubmed | Dynamic epigenetic mechanisms regulate age-dependent SOX9 expression in mouse articular cartilage. | 8.53e-06 | 4 | 42 | 2 | 26806292 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 19759178 | ||
| Pubmed | 8.71e-06 | 33 | 42 | 3 | 18662545 | ||
| Pubmed | 9.55e-06 | 34 | 42 | 3 | 34963132 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 20940257 | ||
| Pubmed | Transcriptional genomics associates FOX transcription factors with human heart failure. | 1.42e-05 | 5 | 42 | 2 | 16952980 | |
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 27383233 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 15492844 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 26744420 | ||
| Pubmed | MTG8 interacts with LHX6 to specify cortical interneuron subtype identity. | 1.45e-05 | 39 | 42 | 3 | 36064547 | |
| Pubmed | 1.61e-05 | 263 | 42 | 5 | 20932939 | ||
| Pubmed | 1.87e-05 | 130 | 42 | 4 | 19386638 | ||
| Pubmed | Epithelial inactivation of Yy1 abrogates lung branching morphogenesis. | 1.95e-05 | 43 | 42 | 3 | 26329601 | |
| Pubmed | 2.06e-05 | 709 | 42 | 7 | 22988430 | ||
| Pubmed | 2.10e-05 | 134 | 42 | 4 | 19030180 | ||
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 16481475 | ||
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 15161102 | ||
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 22547066 | ||
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 38570506 | ||
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 9755172 | ||
| Interaction | GSC interactions | 1.07e-13 | 87 | 41 | 9 | int:GSC | |
| Interaction | FOXP2 interactions | 1.22e-12 | 70 | 41 | 8 | int:FOXP2 | |
| Interaction | SOX13 interactions | 7.52e-11 | 35 | 41 | 6 | int:SOX13 | |
| Interaction | HNF1B interactions | 1.31e-10 | 190 | 41 | 9 | int:HNF1B | |
| Interaction | FEV interactions | 2.37e-10 | 203 | 41 | 9 | int:FEV | |
| Interaction | SP7 interactions | 3.90e-10 | 304 | 41 | 10 | int:SP7 | |
| Interaction | FOXP4 interactions | 1.02e-09 | 98 | 41 | 7 | int:FOXP4 | |
| Interaction | SOX5 interactions | 1.12e-09 | 162 | 41 | 8 | int:SOX5 | |
| Interaction | EGR2 interactions | 1.72e-09 | 171 | 41 | 8 | int:EGR2 | |
| Interaction | CRX interactions | 1.72e-09 | 254 | 41 | 9 | int:CRX | |
| Interaction | NFIB interactions | 1.37e-08 | 142 | 41 | 7 | int:NFIB | |
| Interaction | SOX7 interactions | 1.51e-08 | 82 | 41 | 6 | int:SOX7 | |
| Interaction | SOX6 interactions | 2.74e-08 | 157 | 41 | 7 | int:SOX6 | |
| Interaction | FOXI1 interactions | 3.03e-08 | 92 | 41 | 6 | int:FOXI1 | |
| Interaction | FOXP1 interactions | 4.04e-08 | 256 | 41 | 8 | int:FOXP1 | |
| Interaction | NFIA interactions | 9.45e-08 | 188 | 41 | 7 | int:NFIA | |
| Interaction | SATB1 interactions | 1.22e-07 | 116 | 41 | 6 | int:SATB1 | |
| Interaction | PAX7 interactions | 1.81e-07 | 124 | 41 | 6 | int:PAX7 | |
| Interaction | NFIC interactions | 2.01e-07 | 210 | 41 | 7 | int:NFIC | |
| Interaction | ERG interactions | 3.02e-07 | 223 | 41 | 7 | int:ERG | |
| Interaction | ZFHX4 interactions | 3.67e-07 | 73 | 41 | 5 | int:ZFHX4 | |
| Interaction | SOX2 interactions | PAXIP1 SOX6 SOX5 FOXP1 FOXP4 KMT2D SALL3 SATB1 PUF60 KIAA1217 PHC2 KCMF1 YLPM1 TNRC6A | 4.10e-07 | 1422 | 41 | 14 | int:SOX2 |
| Interaction | SATB2 interactions | 7.85e-07 | 159 | 41 | 6 | int:SATB2 | |
| Interaction | IRF4 interactions | 7.88e-07 | 85 | 41 | 5 | int:IRF4 | |
| Interaction | TLX1 interactions | 1.37e-06 | 175 | 41 | 6 | int:TLX1 | |
| Interaction | LHX3 interactions | 1.90e-06 | 185 | 41 | 6 | int:LHX3 | |
| Interaction | BNC2 interactions | 2.20e-06 | 13 | 41 | 3 | int:BNC2 | |
| Interaction | KLF5 interactions | 2.58e-06 | 195 | 41 | 6 | int:KLF5 | |
| Interaction | FOXL1 interactions | 2.65e-06 | 196 | 41 | 6 | int:FOXL1 | |
| Interaction | PYGO2 interactions | 2.69e-06 | 48 | 41 | 4 | int:PYGO2 | |
| Interaction | TOX interactions | 2.80e-06 | 14 | 41 | 3 | int:TOX | |
| Interaction | PAX8 interactions | 2.96e-06 | 111 | 41 | 5 | int:PAX8 | |
| Interaction | TBR1 interactions | 3.23e-06 | 113 | 41 | 5 | int:TBR1 | |
| Interaction | TBXT interactions | 3.68e-06 | 116 | 41 | 5 | int:TBXT | |
| Interaction | KLF8 interactions | 4.05e-06 | 329 | 41 | 7 | int:KLF8 | |
| Interaction | FOXC1 interactions | 6.34e-06 | 228 | 41 | 6 | int:FOXC1 | |
| Interaction | KLF3 interactions | 6.34e-06 | 228 | 41 | 6 | int:KLF3 | |
| Interaction | PAX9 interactions | 6.43e-06 | 130 | 41 | 5 | int:PAX9 | |
| Interaction | TFDP1 interactions | 7.19e-06 | 133 | 41 | 5 | int:TFDP1 | |
| Interaction | SOX15 interactions | 9.55e-06 | 141 | 41 | 5 | int:SOX15 | |
| Interaction | GCM1 interactions | 1.09e-05 | 68 | 41 | 4 | int:GCM1 | |
| Interaction | MED23 interactions | 1.52e-05 | 266 | 41 | 6 | int:MED23 | |
| Interaction | HNF4A interactions | 1.84e-05 | 275 | 41 | 6 | int:HNF4A | |
| Interaction | AR interactions | PAXIP1 MED12L FOXP1 FOXP4 KMT2D PUF60 CREBBP KIAA1217 EPC1 YLPM1 | 2.22e-05 | 992 | 41 | 10 | int:AR |
| Interaction | PAX2 interactions | 2.65e-05 | 85 | 41 | 4 | int:PAX2 | |
| Interaction | TEAD1 interactions | 2.79e-05 | 176 | 41 | 5 | int:TEAD1 | |
| Interaction | LHX2 interactions | 3.36e-05 | 183 | 41 | 5 | int:LHX2 | |
| Interaction | CCNC interactions | 3.82e-05 | 188 | 41 | 5 | int:CCNC | |
| Interaction | ZBTB39 interactions | 4.09e-05 | 33 | 41 | 3 | int:ZBTB39 | |
| Interaction | GATA2 interactions | 5.01e-05 | 199 | 41 | 5 | int:GATA2 | |
| Interaction | CUX1 interactions | 5.01e-05 | 199 | 41 | 5 | int:CUX1 | |
| Interaction | QSER1 interactions | 5.02e-05 | 100 | 41 | 4 | int:QSER1 | |
| Interaction | HOXB2 interactions | 5.33e-05 | 36 | 41 | 3 | int:HOXB2 | |
| Interaction | NFAT5 interactions | 6.27e-05 | 38 | 41 | 3 | int:NFAT5 | |
| Interaction | TSACC interactions | 8.43e-05 | 7 | 41 | 2 | int:TSACC | |
| Interaction | PAX6 interactions | 9.05e-05 | 366 | 41 | 6 | int:PAX6 | |
| Interaction | KDM1A interactions | 9.22e-05 | 941 | 41 | 9 | int:KDM1A | |
| Interaction | NFIX interactions | 9.34e-05 | 227 | 41 | 5 | int:NFIX | |
| Interaction | SOX11 interactions | 1.12e-04 | 8 | 41 | 2 | int:SOX11 | |
| Interaction | FHL2 interactions | 1.39e-04 | 396 | 41 | 6 | int:FHL2 | |
| Interaction | CCDC73 interactions | 1.44e-04 | 9 | 41 | 2 | int:CCDC73 | |
| Interaction | CTBP1 interactions | 1.60e-04 | 406 | 41 | 6 | int:CTBP1 | |
| Interaction | NCOR2 interactions | 1.89e-04 | 264 | 41 | 5 | int:NCOR2 | |
| Interaction | TLX2 interactions | 1.95e-04 | 142 | 41 | 4 | int:TLX2 | |
| Interaction | TPRX2 interactions | 2.01e-04 | 56 | 41 | 3 | int:TPRX2 | |
| Interaction | KLF16 interactions | 2.04e-04 | 425 | 41 | 6 | int:KLF16 | |
| Interaction | NCOA6 interactions | 2.12e-04 | 145 | 41 | 4 | int:NCOA6 | |
| Interaction | ZMYM2 interactions | 2.14e-04 | 271 | 41 | 5 | int:ZMYM2 | |
| Interaction | ELF5 interactions | 2.23e-04 | 147 | 41 | 4 | int:ELF5 | |
| Interaction | NR2F1 interactions | 2.23e-04 | 58 | 41 | 3 | int:NR2F1 | |
| Interaction | FOXP3 interactions | 2.23e-04 | 432 | 41 | 6 | int:FOXP3 | |
| Interaction | HIC2 interactions | 2.59e-04 | 61 | 41 | 3 | int:HIC2 | |
| Interaction | H2BC10 interactions | 2.59e-04 | 61 | 41 | 3 | int:H2BC10 | |
| Interaction | ZG16 interactions | 2.63e-04 | 12 | 41 | 2 | int:ZG16 | |
| Interaction | H2BC6 interactions | 2.72e-04 | 62 | 41 | 3 | int:H2BC6 | |
| Interaction | SUMO1 interactions | 2.79e-04 | 287 | 41 | 5 | int:SUMO1 | |
| Interaction | CPVL interactions | 2.80e-04 | 156 | 41 | 4 | int:CPVL | |
| Interaction | KLF15 interactions | 2.92e-04 | 290 | 41 | 5 | int:KLF15 | |
| Interaction | ODF2 interactions | 2.94e-04 | 158 | 41 | 4 | int:ODF2 | |
| Interaction | TLX3 interactions | 2.97e-04 | 291 | 41 | 5 | int:TLX3 | |
| Interaction | UBE2I interactions | 3.16e-04 | 654 | 41 | 7 | int:UBE2I | |
| Interaction | VSX1 interactions | 3.27e-04 | 66 | 41 | 3 | int:VSX1 | |
| Interaction | LHX4 interactions | 3.55e-04 | 166 | 41 | 4 | int:LHX4 | |
| Interaction | ETV4 interactions | 3.73e-04 | 69 | 41 | 3 | int:ETV4 | |
| Interaction | KMT2D interactions | 3.79e-04 | 169 | 41 | 4 | int:KMT2D | |
| Interaction | CEP85 interactions | 3.79e-04 | 169 | 41 | 4 | int:CEP85 | |
| Interaction | MAML1 interactions | 4.40e-04 | 73 | 41 | 3 | int:MAML1 | |
| Interaction | SMG7 interactions | 4.52e-04 | 319 | 41 | 5 | int:SMG7 | |
| Interaction | GPBP1 interactions | 4.77e-04 | 75 | 41 | 3 | int:GPBP1 | |
| Interaction | PIAS2 interactions | 4.82e-04 | 180 | 41 | 4 | int:PIAS2 | |
| Interaction | CLTB interactions | 5.34e-04 | 185 | 41 | 4 | int:CLTB | |
| Interaction | MAML2 interactions | 5.39e-04 | 17 | 41 | 2 | int:MAML2 | |
| Interaction | GATA3 interactions | 5.56e-04 | 187 | 41 | 4 | int:GATA3 | |
| Interaction | HNF1A interactions | 5.76e-04 | 80 | 41 | 3 | int:HNF1A | |
| Interaction | EPC1 interactions | 5.97e-04 | 81 | 41 | 3 | int:EPC1 | |
| Interaction | RFX1 interactions | 5.97e-04 | 81 | 41 | 3 | int:RFX1 | |
| Interaction | PHIP interactions | 6.76e-04 | 197 | 41 | 4 | int:PHIP | |
| Interaction | RAI2 interactions | 7.50e-04 | 20 | 41 | 2 | int:RAI2 | |
| Interaction | KAT5 interactions | 7.62e-04 | 358 | 41 | 5 | int:KAT5 | |
| Interaction | DPY30 interactions | 7.70e-04 | 204 | 41 | 4 | int:DPY30 | |
| Cytoband | 2q23.1 | 1.22e-05 | 6 | 42 | 2 | 2q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 3.90e-05 | 71 | 42 | 3 | chr1q22 | |
| Cytoband | 1q32 | 9.35e-04 | 49 | 42 | 2 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q23 | 1.09e-03 | 53 | 42 | 2 | chr2q23 | |
| Cytoband | 1q22 | 1.26e-03 | 57 | 42 | 2 | 1q22 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.61e-10 | 25 | 27 | 5 | 775 | |
| GeneFamily | SRY-boxes | 2.83e-06 | 19 | 27 | 3 | 757 | |
| GeneFamily | Forkhead boxes | 3.52e-05 | 43 | 27 | 3 | 508 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.24e-04 | 18 | 27 | 2 | 91 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 3.82e-08 | 208 | 42 | 7 | M39233 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 2.12e-06 | 131 | 42 | 5 | M39232 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 8.97e-06 | 176 | 42 | 5 | M39223 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP | 1.66e-05 | 200 | 42 | 5 | M8836 | |
| Coexpression | KOYAMA_SEMA3B_TARGETS_DN | 2.37e-05 | 364 | 42 | 6 | M2029 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | 3.81e-05 | 589 | 42 | 7 | M45662 | |
| Coexpression | OSMAN_BLADDER_CANCER_DN | 6.07e-05 | 431 | 42 | 6 | M16858 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.16e-04 | 157 | 42 | 4 | M7733 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 1.78e-04 | 68 | 42 | 3 | M45669 | |
| Coexpression | GSE25087_FETAL_VS_ADULT_TCONV_DN | 2.32e-04 | 188 | 42 | 4 | M4646 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 2.37e-04 | 189 | 42 | 4 | M45678 | |
| Coexpression | GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP | 2.72e-04 | 196 | 42 | 4 | M3106 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 2.80e-04 | 364 | 42 | 5 | M39057 | |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP | 2.88e-04 | 199 | 42 | 4 | M3217 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 2.88e-04 | 199 | 42 | 4 | M8606 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 2.88e-04 | 199 | 42 | 4 | M9255 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 2.93e-04 | 200 | 42 | 4 | M5063 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.93e-04 | 200 | 42 | 4 | M9449 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 2.93e-04 | 200 | 42 | 4 | M7765 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN | 2.93e-04 | 200 | 42 | 4 | M5132 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP | 2.93e-04 | 200 | 42 | 4 | M3526 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP | 2.93e-04 | 200 | 42 | 4 | M4043 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.95e-06 | 205 | 42 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.04e-06 | 127 | 42 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.49e-05 | 298 | 42 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 5.70e-05 | 210 | 42 | 5 | GSM403995_500 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 7.73e-05 | 224 | 42 | 5 | GSM403994_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | 1.02e-04 | 979 | 42 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 1.06e-04 | 983 | 42 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.62e-04 | 139 | 42 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.76e-04 | 142 | 42 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.76e-04 | 142 | 42 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.39e-04 | 61 | 42 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_200 | 2.78e-04 | 160 | 42 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 4.01e-04 | 495 | 42 | 6 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 4.05e-04 | 496 | 42 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 4.14e-04 | 498 | 42 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 4.54e-04 | 328 | 42 | 5 | GSM605756_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.92e-04 | 186 | 42 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 5.64e-04 | 344 | 42 | 5 | GSM538377_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 6.07e-04 | 986 | 42 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.50e-04 | 90 | 42 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#4 | 7.50e-04 | 90 | 42 | 3 | Facebase_RNAseq_e8.5_Floor Plate_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_500 | 7.74e-04 | 91 | 42 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 9.03e-04 | 382 | 42 | 5 | GSM476684_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.60e-04 | 98 | 42 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 9.69e-04 | 388 | 42 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_100 | 9.89e-04 | 99 | 42 | 3 | Facebase_RNAseq_e8.5_Floor Plate_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.05e-03 | 395 | 42 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-07 | 188 | 42 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-07 | 189 | 42 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-07 | 189 | 42 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-07 | 190 | 42 | 5 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-06 | 192 | 42 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 192 | 42 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 193 | 42 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 193 | 42 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 193 | 42 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 193 | 42 | 5 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.11e-06 | 196 | 42 | 5 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-06 | 199 | 42 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 42 | 5 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 42 | 5 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.23e-06 | 200 | 42 | 5 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 132 | 42 | 4 | 295980f70645ee2934145e9959c01f999044da3e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-06 | 142 | 42 | 4 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 160 | 42 | 4 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 160 | 42 | 4 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.92e-05 | 169 | 42 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.31e-05 | 177 | 42 | 4 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 182 | 42 | 4 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-05 | 183 | 42 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.68e-05 | 184 | 42 | 4 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-05 | 184 | 42 | 4 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-05 | 184 | 42 | 4 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 185 | 42 | 4 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 185 | 42 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 185 | 42 | 4 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 185 | 42 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.80e-05 | 186 | 42 | 4 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.80e-05 | 186 | 42 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.80e-05 | 186 | 42 | 4 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-05 | 186 | 42 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.86e-05 | 187 | 42 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.86e-05 | 187 | 42 | 4 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | 3'_v3-blood|World / Manually curated celltypes from each tissue | 2.86e-05 | 187 | 42 | 4 | 9e70e8d7cd8ae517ddf5fd56c69ec16fc33ddff5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 188 | 42 | 4 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.98e-05 | 189 | 42 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 189 | 42 | 4 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 189 | 42 | 4 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-05 | 190 | 42 | 4 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.04e-05 | 190 | 42 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.04e-05 | 190 | 42 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 191 | 42 | 4 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.10e-05 | 191 | 42 | 4 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-05 | 191 | 42 | 4 | f398344aaa79fc93d792e241b634a6afe4aff33d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 191 | 42 | 4 | 11da47d96f44ba629e3299667495e7daddbbe86c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.10e-05 | 191 | 42 | 4 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 191 | 42 | 4 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.10e-05 | 191 | 42 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 191 | 42 | 4 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-05 | 191 | 42 | 4 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-05 | 191 | 42 | 4 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | COVID-19_Moderate-CD8+_T_naive|World / disease group, cell group and cell class | 3.10e-05 | 191 | 42 | 4 | c3385226915097f47d2f197166fc755227438524 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-05 | 191 | 42 | 4 | ffcb2c8dbcf40281b439f4b719b5b341972ffb9a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.10e-05 | 191 | 42 | 4 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-05 | 191 | 42 | 4 | fda432a7f79664e8ffd5d03c1c69ec43bbac994b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 191 | 42 | 4 | ffe88d1ad676c745c76db89f766062fd365329f4 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.17e-05 | 192 | 42 | 4 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | remission-CD4+_T_naive|World / disease stage, cell group and cell class | 3.17e-05 | 192 | 42 | 4 | 4bd94ce876d70f93dbdfad1dcd09e1468213cf57 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.17e-05 | 192 | 42 | 4 | ef8970e5389bd55c1624cd6dd01a7ca7abaa8950 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 3.17e-05 | 192 | 42 | 4 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 3.17e-05 | 192 | 42 | 4 | ad7207810116e73d461242e42071901b6a9f48c6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.17e-05 | 192 | 42 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.17e-05 | 192 | 42 | 4 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | remission-CD4+_T_naive|remission / disease stage, cell group and cell class | 3.17e-05 | 192 | 42 | 4 | d96b2122e28c735d8002ad6eb2d3d52c8e9ccf2b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.23e-05 | 193 | 42 | 4 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.23e-05 | 193 | 42 | 4 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.23e-05 | 193 | 42 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 193 | 42 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | severe-CD4+_Tcm|World / disease stage, cell group and cell class | 3.23e-05 | 193 | 42 | 4 | be0370b2f0093ad0b9d876297bd196d0160f3d99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.30e-05 | 194 | 42 | 4 | 2e2019a7bf57f257f0ff9b24eacff59dbb952ebb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.30e-05 | 194 | 42 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.30e-05 | 194 | 42 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.30e-05 | 194 | 42 | 4 | e0ccf18edbae09fc1068f1e923f1bc0d0ff44195 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.30e-05 | 194 | 42 | 4 | 31a98ce929ee6cf6a9747e384f9a06336af49fd5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.30e-05 | 194 | 42 | 4 | fc0504730ae576ff46ba0bc9f585c53ab78d914c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.30e-05 | 194 | 42 | 4 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.30e-05 | 194 | 42 | 4 | d788d5bd1e651706e7e2d54ada546a5e84f86ff0 | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_naive|Control / Disease group, lineage and cell class | 3.30e-05 | 194 | 42 | 4 | aabcd9f71d8ef54add5c46d8a3e226e3ae3ab124 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-05 | 195 | 42 | 4 | 497d4bfbc38bcafab37e8a9c20bc9141f2e78d2a | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.37e-05 | 195 | 42 | 4 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | COVID-19_Moderate-CD4+_T_naive|World / disease group, cell group and cell class | 3.37e-05 | 195 | 42 | 4 | 38d65cf0895f7a99d789ec3dcbd56a7506706d38 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.37e-05 | 195 | 42 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-05 | 195 | 42 | 4 | 9c71d2a58e772b556e22e2f1d60593580b7aafd8 | |
| ToppCell | COVID-19_Moderate-CD8+_T_naive|COVID-19_Moderate / disease group, cell group and cell class | 3.37e-05 | 195 | 42 | 4 | 22fdc8876883c6b00049ed978260e11f02209b3a | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.37e-05 | 195 | 42 | 4 | 63e132fd6e4318299dd47bbe8ed3bf120efe46dd | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.43e-05 | 196 | 42 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | critical-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.43e-05 | 196 | 42 | 4 | 861665912eb0538b083d3eee77190925b3a43c24 | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.43e-05 | 196 | 42 | 4 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.43e-05 | 196 | 42 | 4 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-05 | 196 | 42 | 4 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.43e-05 | 196 | 42 | 4 | 42e29d5e49cd39f75da715da73e4504704198260 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.79e-04 | 50 | 24 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3 | |
| Drug | TLD-100 | 7.59e-06 | 21 | 42 | 3 | CID000224478 | |
| Drug | stanolone benzoate | 9.95e-06 | 3 | 42 | 2 | ctd:C040109 | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.54e-05 | 190 | 42 | 5 | 5674_UP | |
| Disease | specific developmental disorder (implicated_via_orthology) | 1.07e-08 | 4 | 42 | 3 | DOID:0060038 (implicated_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | 1.39e-05 | 566 | 42 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | pulse pressure measurement | SOX6 EPC2 DYDC1 FOXP1 MBD5 CELF2 KIAA1217 NFKBIA PHC2 TNRC6A | 1.95e-05 | 1392 | 42 | 10 | EFO_0005763 |
| Disease | heart disease (implicated_via_orthology) | 2.18e-05 | 38 | 42 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | neuroticism measurement | 3.66e-05 | 909 | 42 | 8 | EFO_0007660 | |
| Disease | Diffuse Large B-Cell Lymphoma | 6.68e-05 | 55 | 42 | 3 | C0079744 | |
| Disease | unipolar depression, bipolar disorder | 7.19e-05 | 156 | 42 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 7.44e-05 | 57 | 42 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | 8.63e-05 | 517 | 42 | 6 | EFO_0010554 | |
| Disease | cortical surface area measurement | 9.44e-05 | 1345 | 42 | 9 | EFO_0010736 | |
| Disease | brain measurement, neuroimaging measurement | 1.21e-04 | 550 | 42 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.25e-04 | 801 | 42 | 7 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | T wave morphology measurement | 1.78e-04 | 14 | 42 | 2 | EFO_0008398 | |
| Disease | smoking status measurement | 2.00e-04 | 1160 | 42 | 8 | EFO_0006527 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.05e-04 | 15 | 42 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.05e-04 | 15 | 42 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.05e-04 | 15 | 42 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.05e-04 | 15 | 42 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.05e-04 | 15 | 42 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.05e-04 | 15 | 42 | 2 | C1956130 | |
| Disease | age at first sexual intercourse measurement | 2.06e-04 | 383 | 42 | 5 | EFO_0009749 | |
| Disease | chronotype measurement | 2.25e-04 | 882 | 42 | 7 | EFO_0008328 | |
| Disease | autism spectrum disorder (is_implicated_in) | 2.34e-04 | 16 | 42 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 2.65e-04 | 17 | 42 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | facial asymmetry measurement | 3.33e-04 | 19 | 42 | 2 | EFO_0009751 | |
| Disease | depressive symptom measurement | 3.36e-04 | 426 | 42 | 5 | EFO_0007006 | |
| Disease | multisite chronic pain | 3.39e-04 | 95 | 42 | 3 | EFO_0010100 | |
| Disease | Lymphoma, Follicular | 3.70e-04 | 20 | 42 | 2 | C0024301 | |
| Disease | physical activity measurement | 4.05e-04 | 245 | 42 | 4 | EFO_0008002 | |
| Disease | gastroesophageal reflux disease | 4.06e-04 | 101 | 42 | 3 | EFO_0003948 | |
| Disease | wellbeing measurement | 4.16e-04 | 692 | 42 | 6 | EFO_0007869 | |
| Disease | total blood protein measurement | 4.27e-04 | 449 | 42 | 5 | EFO_0004536 | |
| Disease | hematocrit | 5.13e-04 | 1011 | 42 | 7 | EFO_0004348 | |
| Disease | childhood trauma measurement | 5.35e-04 | 24 | 42 | 2 | EFO_0007979 | |
| Disease | diet measurement | 6.39e-04 | 1049 | 42 | 7 | EFO_0008111 | |
| Disease | Sezary Syndrome | 6.79e-04 | 27 | 42 | 2 | C0036920 | |
| Disease | risk-taking behaviour | 7.00e-04 | 764 | 42 | 6 | EFO_0008579 | |
| Disease | mood instability measurement | 8.09e-04 | 128 | 42 | 3 | EFO_0008475 | |
| Disease | mean corpuscular hemoglobin concentration | 8.68e-04 | 1105 | 42 | 7 | EFO_0004528 | |
| Disease | household income | 9.08e-04 | 304 | 42 | 4 | EFO_0009695 | |
| Disease | thyroid stimulating hormone measurement | 1.14e-03 | 323 | 42 | 4 | EFO_0004748 | |
| Disease | smoking cessation | 1.16e-03 | 325 | 42 | 4 | EFO_0004319 | |
| Disease | hemorrhoid | 1.21e-03 | 147 | 42 | 3 | EFO_0009552 | |
| Disease | Burkitt Lymphoma | 1.21e-03 | 36 | 42 | 2 | C0006413 | |
| Disease | hoarding disorder | 1.21e-03 | 36 | 42 | 2 | EFO_0803361 | |
| Disease | breast cancer, ovarian carcinoma | 1.28e-03 | 37 | 42 | 2 | EFO_0001075, MONDO_0007254 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HQQQLALMQKQQLAQ | 591 | Q9H2F5 | |
| HQQQLVQMQRQQLAQ | 586 | Q52LR7 | |
| LQQQLAQQMQQLNTA | 221 | O95319 | |
| QLATALHQQQLMTQQ | 546 | Q2M2I8 | |
| LHQQQLMTQQAALQQ | 551 | Q2M2I8 | |
| RQQQIQHRLQQAQLM | 1851 | Q92793 | |
| VLHLQPQQIMQLQQQ | 416 | Q6ZW49 | |
| SQQQLIQMKLLQQQQ | 1876 | Q86YW9 | |
| IQMKLLQQQQQQRLL | 1881 | Q86YW9 | |
| LQQQQLALQLELEMQ | 81 | Q8WWB3 | |
| HNNLMNQIRSQLAQL | 41 | P15018 | |
| QIQLLSQQNQMLLEQ | 1341 | Q9P219 | |
| INIMNQLSHVNLIQL | 561 | Q32MK0 | |
| VVIMNLNNLNLTQVQ | 201 | Q5KU26 | |
| QQLQALLQQQQAVML | 116 | O15409 | |
| LLQQQQAVMLQQQQL | 121 | O15409 | |
| AAQQLVFQQQLLQMQ | 211 | O15409 | |
| LLQMQQLQQQQHLLS | 221 | O15409 | |
| LQVLLQQQQALMLQQ | 126 | Q9H334 | |
| TQQLAFQQQLLQMQQ | 176 | Q9H334 | |
| LQMQQLQQQHLLSLQ | 186 | Q9H334 | |
| QLQALLQQQQALMLQ | 126 | Q8IVH2 | |
| QLAFQQQLLQMQQLQ | 176 | Q8IVH2 | |
| QQLLQMQQLQQQHLL | 181 | Q8IVH2 | |
| MQQLQQQHLLNLQRQ | 186 | Q8IVH2 | |
| QQQLGQLTLENLQML | 266 | P25963 | |
| LQQKLLLQQMQNQPI | 686 | Q8IZL2 | |
| VILQHTLQQQQQMLQ | 786 | Q5T9S5 | |
| HMQQLLRQQIQANTE | 286 | Q6ZRK6 | |
| LQQQMQQHVQLLTQI | 691 | Q3T8J9 | |
| HQLTHLQSLLNNNQM | 961 | Q9P267 | |
| QLQQLQMQLQLERQH | 226 | Q9P0J7 | |
| HQMQLLQQLLQQQQQ | 291 | O75052 | |
| LEQLMALQQQQIHQL | 206 | Q9BXA9 | |
| QTIAHQQQQLTNLQM | 86 | Q9UHX1 | |
| LMAIQLQNNQLENLP | 391 | Q8TF66 | |
| LRLQLQQMRQLQLQN | 656 | Q5T5P2 | |
| LVNQQLVMAQLLNQQ | 316 | Q01826 | |
| VHQLLQMVNQQQNKF | 326 | O00463 | |
| QQQLLQQQHKINLLQ | 241 | P35712 | |
| ANLQLQTQLAQQQMA | 71 | Q96A04 | |
| AQQQHLMLQTAALQQ | 81 | Q8IXK0 | |
| QQQQLIQQQHKINLL | 201 | Q9UN79 | |
| LQLQAQQHMQKQLLS | 1161 | A4D1E1 | |
| NLQLLFLNNNLLQAM | 506 | O94991 | |
| QQRLQLQQLQHMQHQ | 511 | O15405 | |
| QHLAQLQQLQQMHQK | 56 | P49750 | |
| MQKHTQLQQILQQYQ | 406 | P49750 | |
| LKPELQLMHQQQQLQ | 146 | P0CG23 | |
| QQQQLLQQQHKINLL | 251 | P35711 | |
| LQQQHKINLLQQQIQ | 256 | P35711 | |
| MQALLQIQQGLQTLQ | 466 | Q9NRR5 | |
| QQVAMLNQLSQLNQL | 1396 | Q8NDV7 | |
| LQLQQQRMQLAQKLQ | 3721 | O14686 | |
| QLQALLMQRQLQQSQ | 4221 | O14686 |